Teva Fourth-Quarter Profit Slides as Generic-Drug Revenue Drops

Teva Fourth-Quarter Profit Slides as Generic-Drug Revenue Drops

Akos Stiller/Bloomberg

An employee works with sterile products during the manufacture of pharmaceuticals inside Teva Pharmaceutical Industries Ltd.'s new factory in Godollo, Hungary.